• DiI (DiIC18(3)) Plasma Membrane Probe Guide

  2026-09-09

  DiI (DiIC18(3)) is a lipophilic orange fluorescent membrane dye for visualizing plasma membrane distribution, membrane movement, and labeled cell populations in live or fixed samples. It is suitable for neuronal tracing, migration, adhesion, fusion, and lipoprotein workflows, but not for water-based staining or applications requiring stable intracellular organelle labeling after harsh permeabilization.

• Anti-ROR1 Antibody: Assay Workflows & Use Cases

  2026-09-09

  Anti-ROR1 Antibody (Zilovertamab) supports a practical path from receptor-binding assays to flow cytometry and functional signaling studies. This guide also shows how to use the product responsibly in exploratory liver-injury models without confusing a mechanistic hypothesis with established evidence.

• CNQX Workflow for AMPA/Kainate Circuit Mapping

  2026-09-08

  CNQX provides a practical way to separate AMPA/kainate-driven excitation from NMDA-dependent signaling in cellular, slice, and neurocardiovascular assays. This guide converts its receptor pharmacology into executable workflows, controls, and troubleshooting decisions for synaptic physiology and excitotoxicity research.

• Cy5 NHS ester(Et): Practical Labeling Guide

  2026-09-08

  Cy5 NHS ester(Et) is a water-soluble fluorescent reagent for covalently tagging primary amino groups in proteins, peptides, and other biomolecules. It is suited to fresh labeling workflows for immunofluorescence, flow cytometry, and fluorescence microscopy, but should not be used in ethanol-based procedures or for long-term storage of prepared solutions.

• SB743921: Selective KSP Inhibitor for Cancer Research

  2026-09-07

  SB743921 is a potent and selective kinesin spindle protein inhibitor for mechanistic cancer research. Reported biochemical potency, cellular response data, and tumor xenograft evidence support studies of mitotic arrest, apoptosis, and anti-proliferative activity while leaving assay-specific and translational limitations explicit.

• Thiamet G Workflows for O-GlcNAc Research

  2026-09-07

  Thiamet G enables controlled O-GlcNAcase inhibition for neuronal, cancer, and osteogenic experiments, connecting O-GlcNAc abundance with tau phosphorylation, drug response, and Wnt-driven metabolism. This workflow-centered guide covers dose design, assay selection, cross-domain interpretation, and troubleshooting for more reproducible results.

• Forsythoside E: A Translational PKM2 Strategy

  2026-09-05

  Forsythoside E offers a mechanistically differentiated route into immunometabolic research by promoting PKM2 tetramerization, reducing macrophage glycolysis, and interrupting PKM2–STAT3 signaling. This article translates those findings into practical study design, competitive positioning, and a disciplined path toward sepsis-induced liver injury research.

• Isorhamnetin Oocyte Maturation Workflow

  2026-09-04

  Build a mechanism-oriented oocyte maturation workflow with Isorhamnetin, combining polar body extrusion, ROS, apoptosis, endoplasmic reticulum, and PI3K/Akt readouts. This guide emphasizes solvent control, dose selection, and troubleshooting so the compound functions as more than a generic antioxidant.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-09-04

  The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia (AML) cell growth and survival. By combining gene knockdown, interaction proteomics, RNA-seq, ChIP-seq, and in vivo validation, the authors connect LDB1-dependent transcriptional regulation with apoptosis-related gene control and propose the complex as a potential therapeutic vulnerability.

• SB-3CT Workflows for MMP-9 and ECM Research

  2026-09-03

  Use SB-3CT to connect gelatinase activity with extracellular-matrix remodeling in tumor, vascular, and neural models. This practical guide emphasizes concentration-aware assay design, perineuronal-net workflows, and controls that distinguish MMP-2 effects from MMP-9 biology.

• Forsythoside E: PKM2 Workflow for Macrophages

  2026-09-03

  Forsythoside E connects PKM2 tetramerization with macrophage metabolism, STAT3 signaling, and inflammatory liver injury models. This practical guide covers dose design, orthogonal validation, in vivo translation, and troubleshooting for reproducible immunometabolism workflows.

• Lyso-Tracker Red for Nanoparticle Lysosome Assays

  2026-09-02

  Use Lyso-Tracker Red to connect nanoparticle uptake with lysosomal acidification, distribution, and escape in living immune cells. This practical workflow translates vaccine-adjuvant findings into reproducible fluorescence microscopy and flow-cytometry assays while emphasizing controls that prevent overinterpretation.

• PstS-1 Nanobody for Tuberculosis Molecular Imaging

  2026-09-02

  Dhekale et al. isolated the C8 nanobody against the Mycobacterium tuberculosis phosphate-binding protein PstS-1 and demonstrated its reactivity with bacilli-associated and macrophage-associated antigen. The findings support C8Nb as a candidate molecular-imaging probe, while also highlighting the need for validation in authentic granulomas and human disease settings.

• Anagliptin (SK-0403): DPP-4 and Vascular Research

  2026-09-01

  Anagliptin (SK-0403) is a selective, orally active DPP-4 inhibitor used in diabetes and metabolic research. In rabbit aortic rings, published evidence links its vasorelaxation to Kv channel activation and SERCA pump function, rather than endothelial or cyclic-nucleotide signaling.

• BV6 as a Cell-Death Discriminator in Cancer Research

  2026-09-01

  BV6 is an IAP antagonist that can expose weaknesses in tumor-cell survival signaling. This article explains how lysoptosis research can sharpen apoptosis, radiosensitization, and combination-assay interpretation.

8140 records 1/543 page Next 12345 下5页 Last page